Seyedehsan Navabi, MD

United Medical Doctors

Poster(s):

• P0740 - Mirikizumab Achieved Comprehensive Disease Control in Patients With Ulcerative Colitis From Phase 3 LUCENT-1 and LUCENT-2 Trials
  Sunday, October 22, 2023

  3:30 PM – 7:00 PM PT

• P3577 - Extended Induction of Mirikizumab Sustains Efficacy and Safety Over 104 Weeks for Patients With Moderately to Severely Active Ulcerative Colitis Refractory to Initial Induction
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT